Stay updated on Chemotherapy After PD-1/L1 Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Chemotherapy After PD-1/L1 Inhibitors Clinical Trial page.

Latest updates to the Chemotherapy After PD-1/L1 Inhibitors Clinical Trial page
- Check6 days agoChange DetectedA government funding status banner was added and the page version updated from v3.4.0 to v3.4.1. These changes do not affect the study details or related information.SummaryDifference0.4%

- Check13 days agoChange DetectedAdded a glossary link and updated metadata labels (capitalization changes to Last Update Submitted that Met QC Criteria and No FEAR Act data) along with a new Revision: v3.4.0; these are formatting and labeling changes that do not affect the study content, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.3.4 was added, replacing the previous Revision: v3.3.3 on the page.SummaryDifference0.1%

- Check49 days agoChange DetectedFooter updates add a 'Revision: v3.3.3' tag and remove the 'HHS Vulnerability Disclosure' link (and the prior 'Revision: v3.3.2').SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision label changed from v3.2.0 to v3.3.2. There were no changes to the study content, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check84 days agoChange DetectedThe government operating status notice was removed from the page. The study details, eligibility criteria, and enrollment information remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Chemotherapy After PD-1/L1 Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemotherapy After PD-1/L1 Inhibitors Clinical Trial page.